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RESEARCH ARTICLE
Heart failure and levels of other 
comorbidities in patients with chronic 
obstructive pulmonary disease in a Swedish 
population: a register-based study
Elzbieta Kaszuba1,2*, Håkan Odeberg2, Lennart Råstam2 and Anders Halling2,3
Abstract 
Background: Despite the fact that heart failure and chronic obstructive pulmonary disease (COPD) often exist 
together and have serious clinical and economic implications, they have mostly been studied separately. Our aim 
was to study prevalence of coexisting heart failure and COPD in a Swedish population. A further goal was to describe 
levels of other comorbidity and investigate where the patients received care: primary, secondary care or both.
Methods: We conducted a register-based, cross-sectional study. The population included all people older than 
19 years, living in Östergötland County in Sweden. The data were obtained from the Care Data Warehouse register 
from the year 2006. The diagnosis-based Adjusted Clinical Groups Case-Mix System 7.1 was used to describe the 
comorbidity level.
Results: The prevalence of the diagnosis of heart failure in patients with COPD was 18.8 % while it was 1.6 % in 
patients without COPD. Age standardized prevalence was 9.9 and 1.5 %, respectively. Standardized relative risk for the 
diagnosis of heart failure in patients with COPD was 6.6. The levels of other comorbidity were significantly higher in 
patients with coexisting heart failure and COPD compared to patients with either heart failure or COPD alone. Primary 
care was the only care provider for 36.2 % of patients with the diagnosis of heart failure and 20.7 % of patients with 
coexisting diagnoses of heart failure and COPD. Primary care participated furthermore in shared care of 21.5 % of 
patients with the diagnosis of heart failure and 21.7 % of patients with coexisting diagnoses of heart failure and COPD. 
The share of care between primary and secondary care varied depending on levels of comorbidity both in patients 
with coexisting heart failure and COPD and patients with heart failure alone.
Conclusion: Patients with coexisting diagnoses of heart failure and COPD are common in the Swedish population. 
Patients with coexisting heart failure and COPD have higher levels of other comorbidity than patients with heart 
failure or COPD alone. Primary care in Sweden participates to a great extent in care of patients with diagnoses of heart 
failure alone and coexisting heart failure and COPD.
Keywords: Heart failure, Chronic obstructive pulmonary disease, Diagnosis, Registries, Comorbidity, Primary care, 
Delivery of health care
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Background
Worldwide, chronic obstructive pulmonary disease 
(COPD) is one of the most common chronic diseases 
with overall prevalence of 7.6  % [1] and a heavy eco-
nomic burden [2]. Patients with COPD are a group where 
chronic cardiovascular diseases including heart failure 
occur more frequently than in the general population 
[3]. The risk of developing heart failure in patients with 
COPD is 4.5 times higher than in age-matched controls 
[4]. Coexisting heart failure and COPD can be over-
looked due to similarities in symptoms and signs, which 
is an important clinical implication. The main clinical 
manifestation of COPD and heart failure is dyspnea, 
which in turn is one of the most common causes of con-
sultations in both primary and secondary care, especially 
among elderly patients [5].
The prevalence of undiagnosed heart failure in 
patients with COPD older than 65 years in primary care 
is approximately 20  % [6]. A review of previous studies 
showed that the prevalence of heart failure in patients 
with COPD varied between 10 and 46 % [7].
The prevalence of COPD in patients with heart failure 
is also about 20  % [8, 9]. The prevalence and burden of 
heart failure and COPD correlate with an aging popula-
tion. The proportion of elderly in Sweden is the highest 
in the world with 17.4 % of persons aged ≥65 years and 
is expected to increase until the year 2020 [10]. Manage-
ment of heart failure and COPD is going to be a challenge 
in both primary and secondary care. Despite the fact that 
heart failure and COPD often occur together and have 
serious clinical and economic implications, both diseases 
have so far been mostly studied separately, especially 
on the population level. There is no Swedish data about 
prevalence of coexisting heart failure and COPD.
The aim of this study was to examine the prevalence of 
the diagnosis of heart failure in patients with the diag-
nosis of COPD in the Swedish population. A further aim 
was to describe the levels of other comorbidities and 
investigate where patients with coexisting heart failure 
and COPD receive care: primary, secondary care or both.
Methods
This was a register-based, cross-sectional study. All the 
study population included people older than 19 years, liv-
ing in Östergötland County in Sweden. The data used for 
the study was not openly available and was obtained after 
permission from the Östergötland County council. We 
used data from the Care Data Warehouse register [11]. 
The register collects data concerning consultation and 
diagnosis transferred every month from all public and pri-
vate health care units in both primary and secondary care. 
Diagnoses were recorded according to the Swedish Ver-
sion of International Statistical Classification of Diseases 
and Related Health Problems version 10 (ICD 10). We 
used data from the year 2006. We identified an individual 
as having heart failure or COPD if the diagnosis code I50 
or J44 was recorded on at least one consultation in pri-
mary or secondary care including hospitalization.
The code I50 covers: I50.0-chronic heart failure includ-
ing congestive heart failure, right heart failure secondary 
to left heart failure, I50.1-left ventricular failure with or 
without lung oedema and asthma cardiale, I50.9 heart 
failure, unspecified.
The code J44 comprised the following: J44 chronic 
obstructive lung disease, J44.0 chronic obstructive lung 
disease with acute infection in lower airways, J44.1 
chronic obstructive lung disease with acute exacerbation, 
unspecified, J44.8 other specified chronic obstructive lung 
disease including chronic bronchitis with emphysema.
The diagnosis-based Adjusted Clinical Groups (ACG) 
Case-Mix System 7.1 was used to describe comorbidity 
[12, 13]. Comorbidity on an individual level was meas-
ured when the diagnoses I50 and J44 were excluded and 
it is referred to as the level of other comorbidity.
Each individual was assigned one of six comorbid-
ity levels called resource utilization bands (RUB) graded 
from 0 to 5.
When identifying the place where patients received care 
we used information where the diagnosis of heart failure 
and COPD was made: primary, secondary care or both.
Statistics
Data were analyzed in the STATA version 10 (Stata Cor-
poration, Texas, USA). Descriptive data were presented 
in tables. Differences in proportions between the groups 
were tested using the Chi square test. A p  <  0.05 was 
considered significant. Results for prevalence of heart 
failure and COPD are given for the whole study popula-
tion. Thereafter direct standardizing for age was made. 
Individuals aged 60 and above were chosen arbitrarily as 
a standard population.
Ethics
The study has been approved by the Research Eth-
ics Committee at Linköping University No 147/05 and 
29/06.
Results
The study population consisted of 313,977 individuals. 
The diagnosis of heart failure was registered in 1.8 % and 
the diagnosis of COPD was registered in 1.2  % of the 
study population. The mean age in patients with the diag-
nosis of heart failure was 78.4 years (CI 78.0–78.7). The 
mean age of patients with the diagnosis of COPD was 
70.5  years (CI 70.2–70.9). The prevalence of both diag-
noses increased with age (Table 1). The prevalence of the 
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diagnosis of heart failure in patients with the diagnosis 
of COPD was 18.8 and 1.6 % in patients without COPD. 
After standardizing for age the prevalence was 9.9 and 
1.5 %, respectively. Standardized relative risk for the diag-
nosis of heart failure in patients with COPD was 6.6.
The prevalence of the diagnosis of heart failure 
increased with age in women and men in both groups 
and reached 35.7 % in men with COPD ≥80 years (Fig. 1). 
The prevalence of the diagnosis of heart failure was sig-
nificantly higher in both women and men with COPD 
comparing to women and men without COPD in all age 
groups apart from the age group 20–39 years.
The most common comorbid condition in all three 
groups of patients: heart failure alone, COPD alone and 
coexisting heart failure and COPD was essential (pri-
mary) hypertension coded with either I10 or I10.9. The 
latter code is used only in secondary care. The comorbid 
diagnoses are summarized in Table 2.
The levels of other comorbidity were significantly 
higher in patients with coexisting heart failure and 
COPD comparing to patients with heart failure or COPD 
alone (Table 3).
The proportion of individuals with higher levels of 
other comorbidity (RUB 3–5) was 95 % in the group with 
coexisting heart failure and COPD, while in the group 
with heart failure alone it was 90.7  % and in the group 
with COPD alone it was 73.3 %.
Primary care was the only care provider to 36.2  % of 
patients with the diagnosis of heart failure and 20.7  % 
of patients with coexisting heart failure and COPD. Fur-
thermore, primary care participated in shared care of 
21.5 % of patients with the diagnosis of heart failure alone 
and 21.7 % of patients with coexisting diagnoses of heart 
failure and COPD.
The share of care given by primary and secondary care 
varied depending on levels of other comorbidity both in 
patients with heart failure without COPD and patients 
with coexisting heart failure and COPD (Fig.  2). The 
higher the level of other comorbidity the larger the par-
ticipation of secondary health care was. Among patients 
with the highest level of other comorbidity (RUB 5) in 
the group with coexisting heart failure and COPD 11 % 
received care only in primary care, 29 % received shared 
care and 60 % received care only in secondary care.
Discussion
We found that the prevalence of the diagnosis of heart 
failure in patients with the diagnosis of COPD was signif-
icantly higher than in patients without COPD. The levels 
of other comorbidity were significantly higher in patients 
with coexisting heart failure and COPD comparing with 
Table 1 Prevalence of diagnoses COPD, heart failure and coexisting COPD and heart failure in the study population
Variable 20–39 years 40–59 years 60–79 years >80 years Total
Women 47,419 53,539 41,359 16,386 158,703
Men 52,020 55,164 38,443 9647 155,274
COPD in total population 31 (0.03 %) 536 (0.4 %) 2280 (2.8 %) 889 (3.4 %) 3736 (1.2 %)
Heart failure in total population 34 (0.03 %) 328 (0.3 %) 2132 (2.6 %) 3045 (11.6 %) 5539 (1.89 %)
Heart failure in patients with COPD 0 (0 %) 26 (4.6 %) 367 (16.1 %) 307 (34.5 %) 700 (18.8 %)
Heart failure in patients without COPD 34 (0.03 %) 302 (0.3 %) 1765 (2.3 %) 2738 (10.9 %) 4839 (1.6 %)
0
0,05
0,1
0,15
0,2
0,25
0,3
0,35
20-39 years 40-59 years 60-79 years ≥ 80 years
0,02% 0,15%
1,67%
9,82%
0,00%
3,99%
13,93%
33,17%
Women without COPD
Women with COPD
a
0
0,05
0,1
0,15
0,2
0,25
0,3
0,35
0,4
20-39 years 40-59 years 60-79 years ≥ 80 years
0,05% 0,40%
2,93%
12,74%
0,00%
6,19%
18,58%
35,73%
Men without COPD 
Men with COPD
b
Fig. 1 Prevalence of the diagnosis of heart failure in female (a) and 
male (b) patients with and without coexisting COPD in different age 
groups
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patients with heart failure or COPD alone. Primary care 
alone delivered care to 20.7  % of patients with coexist-
ing heart failure and COPD and to a further 21.7 % who 
simultaneously received care from primary and second-
ary care.
Completeness and accuracy of data
The Care Data Warehouse Register comprised data 
from the whole population in the Östergötland County, 
which is the strength of our study. All consultations 
were recorded in electronic charts and the diagnosis 
was required at each consultation. We analyzed data 
from both primary and secondary care. A previous study 
showed usefulness of data from the Care Data Ware-
house register in Östergötland in estimating the preva-
lence of chronic diseases such as diabetes, hypertension, 
ischemic heart disease, asthma and COPD and showed 
that the longer period of analysis corresponded to better 
capturing of cases [14]. The limitation of our study is a 
short period we analyzed. Our choice was anchored 
in Swedish clinical practice. In Swedish primary care 
patients with chronic diseases are actively checked at 
least once a year. Patients with COPD are summoned for 
a nurse-led follow-up and the presence of a specially edu-
cated asthma/COPD nurse is a requirement for each pri-
mary health care centre.
Nurse-led follow up of patients with heart failure is 
common in Swedish secondary care [15]. Östergötland 
was the leading county in Sweden in structured heart 
failure management in primary care [16].
A previous study showed that the diagnosis of COPD 
from a register in Sweden has an acceptable validity for 
being used in epidemiological research [17]. COPD in 
Sweden is usually diagnosed in primary care according to 
the Global Initiative for Chronic Obstructive Lung Dis-
ease (GOLD) criteria [18]. Spirometry as a gold standard 
Table 2 Summarizing of the most common diagnostic codes
Patients with COPD 
n = 3736
Code Number (%) Patients with heart 
failure n = 4839
Code Number (%) Patients with COPD 
and heart failure 
n = 700
Code Number (%)
Essential (primary) 
hypertension
I10, I10.9 1196 (32) Essential (primary) 
hypertension
I10, I10.9 2303 (47.6) Essential (primary) 
hypertension
10, I10.9 284 (40.6)
Observation for 
suspected disease or 
condition
Z039 628 (16.8) Observation for 
suspected disease or 
condition
Z03.9 1472 (30.4) Observation for 
suspected disease or 
condition
Z03.9 251 (35.9)
Heart failure, unspeci-
fied
I50.9 526 (14.1) Atrial fibrillation and 
atrial flutter, unspeci-
fied
I48.9 1380 (28.5) Atrial fibrillation and 
atrial flutter,  
unspecified
I48.9 199 (28.4)
Unspecified acute 
lower respiratory 
infection
J22 383 (10.3) Type 2 diabetes 
mellitus, without 
complications
E11.9 958 (19.8) Old myocardial  
infarction
I25.2 166 (23.7)
Type 2 diabetes 
mellitus, without 
complications
E11.9 350 (9.4) Atrial fibrillation and 
atrial flutter, unspeci-
fied
I48.9 931 (19.2) Type 2 diabetes mellitus, 
without complications
E11.9 149 (21.3)
Atrial fibrillation and 
atrial flutter, unspeci-
fied
I48.9 312 (8.4) Chronic ischaemic 
heart disease, 
unspecified
I25.9 910 (18.8) Chronic ischaemic heart 
disease, unspecified
I25.9 136 (19.4)
Table 3 Distribution of levels of other comorbidity measured by RUB (resource utilization band) in the study population
* p value describes differences between groups with and without COPD
Total Patients without COPD Patients with COPD p value*
No heart failure Heart failure No heart failure Heart failure
RUB 0 102,071 (32.51 %) 101,835 (33.34 %) 81 (1.65 %) 150 (4.49 %) 5 (0.71 %) 0.000
RUB 1 44,126 (14.05 %) 43,855 (14.36 %) 86 (1.78 %) 181 (5.96 %) 4 (0.57 %) 0.001
RUB 2 65,322 (20.8 %) 64,533 (21.13 %) 282 (5.83 %) 481 (15.84 %) 26 (3.71 %) 0.000
RUB 3 89,042 (28.36 %) 84,602 (27.7 %) 2514 (51.95 %) 1603 (52.80 %) 323 (46.14 %) 0.000
RUB 4 10,383 (3.31 %) 10,383 (3.31 %) 1234 (25.50 %) 434 (14.30 %) 203 (29 %) 0.000
RUB 5 3033 (0.97 %) 2065 (0.68 %) 642 (13.27 %) 187 (6.16 %) 139 (19.89 %) 0.000
Total 313,977 (100 %) 305,402 (100 %) 4839 (100 %) 3036 (100 %) 700 (100 %) 0.000
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in diagnosing COPD is widely available in primary care 
[19, 20]. Echocardiography as a gold standard in diag-
nosing heart failure is not as much accessible to gen-
eral practitioners as spirometry and requires referral to 
specialized care. A previous Swedish study showed that 
echocardiography was performed only in about 30 % of 
patients with suspected heart failure [21]. Östergötland 
County was a leader in Sweden in use of natriuretic pep-
tides in patients with suspected heart failure in primary 
care [22]. The limitation of our study was that, due to 
ethical reasons, we could not validate recorded diagnoses 
against the original medical records. At the same time we 
have no premises to suspect that the diagnoses registered 
in the Care Data Warehouse were non-accurate.
Interpretation of the results
We found that the diagnosis of heart failure occurred in 
1.8 % of the study population.
This is exactly the same as the crude prevalence 
reported in a recently published Swedish register study 
[23]. According to this study the estimated prevalence of 
heart failure in Sweden was 2.2 % in year 2010. Estima-
tion made about 15 years ago was 2.5 % [24].
The prevalence of the diagnosis of COPD was 1.2  %. 
Our result is considerably lower than prevalence of 
COPD in the general population in Sweden estimated at 
about 6  % [25]. The discrepancy was expected because 
epidemiological studies regarding COPD used to be per-
formed in individuals aged at least 40  years due to the 
onset of the illness, while we included individuals aged 
20 and older in order to study the whole adult popula-
tion. After excluding younger patients aged ≤40 years the 
prevalence of COPD was 1.7 %, which did not change our 
results considerably.
We searched only for the diagnostic code J44, while 
in studies from other countries chronic bronchitis and 
emphysema J40–J43 were also included [26]. By that 
choice we wanted to decrease a risk of the non-accurate 
COPD diagnosis. In view of present guidelines for the 
diagnosis of COPD in Sweden the diagnostic code J44 is 
expected to be used for patients with COPD after doing 
the spirometry. This code is expected even in patients 
with emphysema caused by COPD. We think that preva-
lence of COPD in our study was underestimated due to 
poor registering of the diagnosis code in medical records.
Prevalence of the diagnosis of heart failure increased 
with age in patients without and with COPD as reported 
in previous studies [27, 28]. In our study the prevalence of 
the diagnosis of heart failure in individuals ≥80 years in 
the general population was approximately 11 % and was 
comparable with previously reported data from epide-
miological studies, but differed from the recent Swedish 
register study where it was about 19  % [23]. A differ-
ence between genders was reported in a Swedish epide-
miological study. A report from 2001 [29] showed that 
heart failure was more prevalent in men up to 80  years 
of age, thereafter, heart failure was more prevalent in 
women. Our data from 2006 showed no significant differ-
ence between women and men even aged ≥80 years. The 
newer study [23] with data collection up to 2010 showed, 
in contrast to the first study, that prevalence was higher 
in men in groups 80–89 and 90–99.
Women dominated slightly in the group ≥100  years. 
The populations in all three studies were large enough to 
venture to assert that the age limit for healthy survivals 
has moved during one decade to centenarians, probably 
thanks to improved strategies in heart failure manage-
ment in Sweden.
The diagnosis of heart failure occurred in 18.8  % of 
patients with COPD while in patients without COPD 
it occurred in 1.6  %. Due to differences in age between 
groups with and without COPD standardizing for age was 
made and standardized prevalence was 9.9 % in patients 
with COPD and 1.5 % in patients without COPD. Previ-
ously reported prevalence of heart failure in patients with 
COPD varied between 10 and 46 % [7]. These data were 
obtained in different settings and different procedures 
were used to make the diagnosis of heart failure, ranging 
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Fig. 2 Share of care in patients with heart failure without (a) and 
with (b) chronic obstructive pulmonary disease. PHC primary health 
care, SHC secondary health care, RUB resource utilization band
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from clinical symptoms, standardized chronic heart fail-
ure score, the use of natriuretic peptides for assessment 
of left and right ventricle function by ventriculography or 
echocardiography. The highest prevalence was reported 
in emergency setting among patients with symptomatic 
dyspnea [30]. The diagnosis of heart failure in this study 
was established by assessment of left and right ventricle 
function by radionuclide ventriculography. The preva-
lence of the diagnosis of heart failure found in our study 
(18.8 %) is in agreement with the prevalence of heart fail-
ure in patients with COPD (20.5  %) found in the Dutch 
study conducted in primary health care setting [6]. The 
diagnosis of heart failure in that study was made by using 
echocardiography. In our register-based study we could 
not trace how the diagnosis of heart failure was made.
Differences in frequency of the diagnosis of heart fail-
ure between individuals with and without COPD were 
significant in all age groups except the age 20–39. Calcu-
lations in this age group were affected by 0 % prevalence 
of heart failure diagnosis in individuals with COPD.
Comorbidity in patients with heart failure and COPD is 
well-known and widely reported [31–37]. The most com-
mon comorbid condition in all three groups of patients 
in our study: COPD alone, heart failure alone and coex-
isting heart failure and COPD was essential (primary) 
hypertension coded with either I10 or I10.9. The latter 
code is used only in secondary care.
The next common diagnosis code in all three groups 
was Z03.9 Observation for suspected disease or condi-
tion, unspecified. This code does not allow identifying 
of disorder. If the register data should be available as a 
source of research e.g. prevalence studies, more spe-
cific diagnosis codes are desirable. Comorbidity should 
be considered as an important factor when analyzing 
needs for health care resources. ACG Case Mix is able 
to describe comorbidity in a quantitative way and is 
used in the Swedish health care system for calculation 
of payment rates. When analyzing comorbidity levels 
we excluded the main diagnoses of heart failure and 
COPD. This was done in order to study the importance 
of other comorbidity that otherwise would be hidden by 
the heavy burden connected with the diagnosis of heart 
failure or COPD. The levels of other comorbidity cal-
culated in this way were significantly higher in patients 
with coexisting heart failure and COPD. That implies a 
greater need for health care and more extensive resource 
utilization than in patients with only heart failure or 
COPD.
The delivery of care to patients with coexisting heart 
failure and COPD has not been studied previously. 
When presenting our results in Fig. 2 we omitted groups 
with the lowest levels of other comorbidity (RUB 0 and 
1) due to a small number of patients in those groups. 
As expected, the higher the levels of other comorbidity 
the greater participation of secondary care. We did not 
trace what kind of care patients got in secondary health 
care units. It might be hospitalizations or consultations 
in specialized outpatient clinics. Taking into considera-
tion the heavy burden of both heart failure and COPD 
the participation of primary care was large in our opin-
ion. Half of the patients with coexisting heart failure and 
COPD and lower levels of other comorbidity (RUB 2) 
received care only in primary care. In the group with the 
highest level of other comorbidity (RUB 5) and coexist-
ing heart failure and COPD primary care was involved 
in almost 40 % of patients, either alone or together with 
secondary care. In the case of patients with heart failure 
without COPD the percentage was even higher (74  %). 
Shared care can be explained by organization of the 
Swedish health care system and established co-operation 
between primary and secondary care units concerning 
chronic diseases.
It is noteworthy that a considerable part of patients 
with the highest level of other comorbidity (RUB 5) 
received care only in primary care. A possible explana-
tion might be that the patients were optimally treated 
and requirement of secondary care was unnecessary dur-
ing one year period we analyzed. It might also be a matter 
of the terminal phase of illness and palliative care where 
primary care plays a central role.
Conclusion
Our study showed that the prevalence of the diagnosis 
of heart failure in patients with the diagnosis of COPD is 
common in the Swedish population. Patients with coex-
isting heart failure and COPD have higher levels of other 
comorbidity than patients with heart failure or COPD 
alone. Primary care in Sweden participates to a great 
extent in care of patients with heart failure and coexisting 
COPD as well as without COPD.
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